Optical coherence tomography for the monitoring of neovascular age-related macular degeneration: A systematic review

Ophthalmology

Volumn 122, Issue 2, 2015, Pages 399-406

  Castillo, Mayret M ^a   Mowatt, Graham ^a   Elders, Andrew ^a,b   Lois, Noemi ^c   Fraser, Cynthia ^a   Hernández, Rodolfo ^a,d   Amoaku, Winfried ^e   Burr, Jennifer M ^f   Lotery, Andrew ^g   Ramsay, Craig R ^a   Azuara Blanco, Augusto ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f UNIVERSITY OF ST ANDREWS   (United Kingdom)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE RELATED MACULAR DEGENERATION; AMSLER CHART; AUTOFLUORESCENCE IMAGING; CLINICAL EVALUATION; COLOR FUNDUS PHOTOGRAPHY; EYE FUNDUS; FUNDUS FLUORESCEIN ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MEDICAL PHOTOGRAPHY; META ANALYSIS; NEOVASCULAR AGE RELATED MACULAR DEGENERATION; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; RETINA FLUORESCEIN ANGIOGRAPHY; REVIEW; SLIT LAMP; SYSTEMATIC REVIEW; VISUAL ACUITY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VISUAL SYSTEM EXAMINATION; WET MACULAR DEGENERATION;

DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL COHERENCE; WET MACULAR DEGENERATION;

EID: 84921463935     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.07.055     Document Type: Review

References (26)

1. D.M. Brown, M. Michels, and P.K. Kaiser Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study Ophthalmology 116 2009 57 65
2. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group D.F. Martin, M.G. Maguire, and S.L. Fine Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 2012 1388 1398
3. IVAN Study Investigators U. Chakravarthy, S.P. Harding, and C.A. Rogers Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial Ophthalmology 119 2012 1399 1411
4. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
5. Macular Photocoagulation Study Group Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial Arch Ophthalmol 109 1991 1220 1231
6. Macular Photocoagulation Study Group Laser photocoagulation for juxtafoveal choroidal neovascularization: five-year results from randomized clinical trials Arch Ophthalmol 112 1994 500 509
7. Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report 1 Arch Ophthalmol 117 1999 1329 1345
8. Royal College of Ophthalmologists. AMD Guidelines Group. Age-related macular degeneration: guidelines for management. 2013. Available at: http://www.rcophth.ac.uk/page.asp?section=451. Accessed August 7, 2014.
9. American Academy of Ophthalmology Retina/Vitreous Panel Preferred Practice Pattern Guidelines: Age-Related Macular Degeneration 2011 American Academy of Ophthalmology San Francisco, CA Available at: http://www.aao.org/ppp Accessed August 7, 2014
10. P.F. Whiting, A.W. Rutjes, M.E. Westwood QUADAS-2 Group QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Ann Intern Med 155 2011 529 536
11. Mowatt G, Azuara-Blanco A, Burr H, et al. HTA-10/57/22. Systematic review and economic modelling of optical coherence tomography (OCT) for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration. Health Technol Assess In press. Available at: http://www.nets.nihr.ac.uk/projects/hta/105722. Accessed August 7, 2014.
12. R.N. Khurana, B. Dupas, and N.M. Bressler Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization Ophthalmology 117 2010 1376 1380
13. N. Eter, and R.F. Spaide Comparison of fluorescein angiography and optical coherence tomography for patients with choroidal neovascularization after photodynamic therapy Retina 25 2005 691 696
14. A. Giani, C. Luiselli, and D.D. Esmaili Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization Invest Ophthalmol Vis Sci 52 2011 5579 5586
15. A. Henschel, G. Spital, A. Lommatzsch, and D. Pauleikhoff Optical coherence tomography in neovascular age related macular degeneration compared to fluorescein angiography and visual acuity Eur J Ophthalmol 19 2009 831 835
16. C.D. Regillo, K.A. Blade, P.H. Custis, and S.R. O'Connell Evaluating persistent and recurrent choroidal neovascularization. The role of indocyanine green angiography Ophthalmology 105 1998 1821 1826
17. A. Salinas-Alaman, A. Garcia-Layana, and M.J. Maldonado Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration Am J Ophthalmol 140 2005 23 28
18. A. van de Moere, S.S. Sandhu, and S.J. Talks Correlation of optical coherence tomography and fundus fluorescein angiography following photodynamic therapy for choroidal neovascular membranes Br J Ophthalmol 90 2006 304 306
19. M.E. van Velthoven, M.D. de Smet, and R.O. Schlingemann Added value of OCT in evaluating the presence of leakage in patients with age-related macular degeneration treated with PDT Graefes Arch Clin Exp Ophthalmol 244 2006 1119 1123
20. N. Lois, V. McBain, and E. Abdelkader Retinal pigment epithelial atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor therapy Retina 33 2013 13 22
21. V.A. McBain, R. Kumari, J. Townend, and N. Lois Geographic atrophy in retinal angiomatous proliferation Retina 31 2011 1043 1052
22. M.M. Leeflang, J.J. Deeks, and C. Gatsonis Systematic reviews of diagnostic test accuracy Ann Intern Med 149 2008 889 897
23. P. Glasziou, L. Irwig, and J.J. Deeks When should a new test become the current reference standard? Ann Intern Med 149 2008 816 822
24. S.Y. Cohen, L. Dubois, and S. Nghiem-Buffet Retinal pseudocysts in age-related geographic atrophy Am J Ophthalmol 150 2010 211 217
25. D.V. Do, E.W. Gower, and S.D. Cassard Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study Ophthalmology 119 2012 771 778
26. B.G. Busbee, A.C. Ho, D.M. Brown HARBOR Study Group Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration Ophthalmology 120 2013 1046 1056